APO Research
Talk to an analyst

APO RESEARCH · REPORT

Dry Eye Syndrome Treatment

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Dry Eye Syndrome Treatment Market Analysis and Forecast 2026-2032

23 December 2025203 pages

Choose your research edition.

Industry ResearchDry Eye Syndrome Treatment Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Dry Eye Syndrome Treatment Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Dry Eye Syndrome Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Dry Eye Syndrome Treatment Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Dry Eye Syndrome Treatment Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

The global Dry Eye Syndrome Treatment market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Dry Eye Syndrome Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Dry Eye Syndrome Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Dry Eye Syndrome Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Dry Eye Syndrome Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Dry Eye Syndrome Treatment include Sun Pharmaceutical, Johnson & Johnson, Novartis, United Laboratories, Jianfeng Group, Alcon, AbbVie, URSAPHARM and Thea pharmaceuticals, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Dry Eye Syndrome Treatment, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Dry Eye Syndrome Treatment, also provides the sales of main regions and countries. Of the upcoming market potential for Dry Eye Syndrome Treatment, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Dry Eye Syndrome Treatment sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Dry Eye Syndrome Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Dry Eye Syndrome Treatment sales, projected growth trends, production technology, application and end-user industry.

Dry Eye Syndrome Treatment Segment by Company

Sun Pharmaceutical

Johnson & Johnson

Novartis

United Laboratories

Jianfeng Group

Alcon

AbbVie

URSAPHARM

Thea pharmaceuticals

SIMILASAN

Santen Pharma

Rohto

Prestige Consumer Healthcare

OmniVision Pharma

LION

Kenvue (VISINE)

Bausch & Lomb

Akorn

Dry Eye Syndrome Treatment Segment by Type

Liquid Wipes

Liquid Drops

Eye Ointment

Gel

Other

Dry Eye Syndrome Treatment Segment by Application

Clinic

Hospital

Home Care

Dry Eye Syndrome Treatment Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dry Eye Syndrome Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Dry Eye Syndrome Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dry Eye Syndrome Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Dry Eye Syndrome Treatment in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Dry Eye Syndrome Treatment manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Dry Eye Syndrome Treatment sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Dry Eye Syndrome Treatment Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Liquid Wipes Major Manufacturers Table 3. Liquid Drops Major Manufacturers Table 4. Eye Ointment Major Manufacturers Table 5. Gel Major Manufacturers Table 6. Other Major Manufacturers Table 7. Global Dry Eye Syndrome Treatment Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Clinic Major Manufacturers Table 9. Hospital Major Manufacturers Table 10. Home Care Major Manufacturers Table 11. Dry Eye Syndrome Treatment Industry Trends Table 12. Dry Eye Syndrome Treatment Industry Drivers Table 13. Dry Eye Syndrome Treatment Industry Opportunities and Challenges Table 14. Dry Eye Syndrome Treatment Industry Restraints Table 15. Global Dry Eye Syndrome Treatment Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 16. Global Dry Eye Syndrome Treatment Revenue by Region (2021-2026) & (US$ Million) Table 17. Global Dry Eye Syndrome Treatment Revenue by Region (2027-2032) & (US$ Million) Table 18. Global Dry Eye Syndrome Treatment Revenue Market Share by Region (2021-2026) Table 19. Global Dry Eye Syndrome Treatment Revenue Market Share by Region (2027-2032) Table 20. Global Dry Eye Syndrome Treatment Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 21. Global Dry Eye Syndrome Treatment Sales by Region (2021-2026) & (k units) Table 22. Global Dry Eye Syndrome Treatment Sales by Region (2027-2032) & (k units) Table 23. Global Dry Eye Syndrome Treatment Sales Market Share by Region (2021-2026) Table 24. Global Dry Eye Syndrome Treatment Sales Market Share by Region (2027-2032) Table 25. Global Dry Eye Syndrome Treatment Revenue by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Dry Eye Syndrome Treatment Revenue Market Share by Manufacturers (2021-2026) Table 27. Global Dry Eye Syndrome Treatment Sales by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Dry Eye Syndrome Treatment Sales Market Share by Manufacturers (2021-2026) Table 29. Global Dry Eye Syndrome Treatment Sales Price (USD/unit) of Manufacturers (2021-2026) Table 30. Global Dry Eye Syndrome Treatment Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 31. Global Dry Eye Syndrome Treatment Key Manufacturers Manufacturing Sites & Headquarters Table 32. Global Dry Eye Syndrome Treatment Manufacturers, Product Type & Application Table 33. Global Dry Eye Syndrome Treatment Manufacturers' Establishment Date Table 34. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 35. Global Dry Eye Syndrome Treatment by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 36. Global Dry Eye Syndrome Treatment Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Dry Eye Syndrome Treatment Revenue by Type (2021-2026) & (US$ Million) Table 38. Global Dry Eye Syndrome Treatment Revenue by Type (2027-2032) & (US$ Million) Table 39. Global Dry Eye Syndrome Treatment Revenue Market Share by Type (2021-2026) Table 40. Global Dry Eye Syndrome Treatment Revenue Market Share by Type (2027-2032) Table 41. Global Dry Eye Syndrome Treatment Sales by Type 2021 VS 2025 VS 2032 (k units) Table 42. Global Dry Eye Syndrome Treatment Sales by Type (2021-2026) & (k units) Table 43. Global Dry Eye Syndrome Treatment Sales by Type (2027-2032) & (k units) Table 44. Global Dry Eye Syndrome Treatment Sales Market Share by Type (2021-2026) Table 45. Global Dry Eye Syndrome Treatment Sales Market Share by Type (2027-2032) Table 46. Global Dry Eye Syndrome Treatment Price by Type (2021-2026) & (USD/unit) Table 47. Global Dry Eye Syndrome Treatment Price by Type (2027-2032) & (USD/unit) Table 48. Global Dry Eye Syndrome Treatment Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Dry Eye Syndrome Treatment Revenue by Application (2021-2026) & (US$ Million) Table 50. Global Dry Eye Syndrome Treatment Revenue by Application (2027-2032) & (US$ Million) Table 51. Global Dry Eye Syndrome Treatment Revenue Market Share by Application (2021-2026) Table 52. Global Dry Eye Syndrome Treatment Revenue Market Share by Application (2027-2032) Table 53. Global Dry Eye Syndrome Treatment Sales by Application 2021 VS 2025 VS 2032 (k units) Table 54. Global Dry Eye Syndrome Treatment Sales by Application (2021-2026) & (k units) Table 55. Global Dry Eye Syndrome Treatment Sales by Application (2027-2032) & (k units) Table 56. Global Dry Eye Syndrome Treatment Sales Market Share by Application (2021-2026) Table 57. Global Dry Eye Syndrome Treatment Sales Market Share by Application (2027-2032) Table 58. Global Dry Eye Syndrome Treatment Price by Application (2021-2026) & (USD/unit) Table 59. Global Dry Eye Syndrome Treatment Price by Application (2027-2032) & (USD/unit) Table 60. Sun Pharmaceutical Company Information Table 61. Sun Pharmaceutical Business Overview Table 62. Sun Pharmaceutical Dry Eye Syndrome Treatment Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 63. Sun Pharmaceutical Dry Eye Syndrome Treatment Product Portfolio Table 64. Sun Pharmaceutical Recent Development Table 65. Johnson & Johnson Company Information Table 66. Johnson & Johnson Business Overview Table 67. Johnson & Johnson Dry Eye Syndrome Treatment Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 68. Johnson & Johnson Dry Eye Syndrome Treatment Product Portfolio Table 69. Johnson & Johnson Recent Development Table 70. Novartis Company Information Table 71. Novartis Business Overview Table 72. Novartis Dry Eye Syndrome Treatment Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 73. Novartis Dry Eye Syndrome Treatment Product Portfolio Table 74. Novartis Recent Development Table 75. United Laboratories Company Information Table 76. United Laboratories Business Overview Table 77. United Laboratories Dry Eye Syndrome Treatment Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 78. United Laboratories Dry Eye Syndrome Treatment Product Portfolio Table 79. United Laboratories Recent Development Table 80. Jianfeng Group Company Information Table 81. Jianfeng Group Business Overview Table 82. Jianfeng Group Dry Eye Syndrome Treatment Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 83. Jianfeng Group Dry Eye Syndrome Treatment Product Portfolio Table 84. Jianfeng Group Recent Development Table 85. Alcon Company Information Table 86. Alcon Business Overview Table 87. Alcon Dry Eye Syndrome Treatment Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 88. Alcon Dry Eye Syndrome Treatment Product Portfolio Table 89. Alcon Recent Development Table 90. AbbVie Company Information Table 91. AbbVie Business Overview Table 92. AbbVie Dry Eye Syndrome Treatment Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. AbbVie Dry Eye Syndrome Treatment Product Portfolio Table 94. AbbVie Recent Development Table 95. URSAPHARM Company Information Table 96. URSAPHARM Business Overview Table 97. URSAPHARM Dry Eye Syndrome Treatment Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. URSAPHARM Dry Eye Syndrome Treatment Product Portfolio Table 99. URSAPHARM Recent Development Table 100. Thea pharmaceuticals Company Information Table 101. Thea pharmaceuticals Business Overview Table 102. Thea pharmaceuticals Dry Eye Syndrome Treatment Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. Thea pharmaceuticals Dry Eye Syndrome Treatment Product Portfolio Table 104. Thea pharmaceuticals Recent Development Table 105. SIMILASAN Company Information Table 106. SIMILASAN Business Overview Table 107. SIMILASAN Dry Eye Syndrome Treatment Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. SIMILASAN Dry Eye Syndrome Treatment Product Portfolio Table 109. SIMILASAN Recent Development Table 110. Santen Pharma Company Information Table 111. Santen Pharma Business Overview Table 112. Santen Pharma Dry Eye Syndrome Treatment Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 113. Santen Pharma Dry Eye Syndrome Treatment Product Portfolio Table 114. Santen Pharma Recent Development Table 115. Rohto Company Information Table 116. Rohto Business Overview Table 117. Rohto Dry Eye Syndrome Treatment Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 118. Rohto Dry Eye Syndrome Treatment Product Portfolio Table 119. Rohto Recent Development Table 120. Prestige Consumer Healthcare Company Information Table 121. Prestige Consumer Healthcare Business Overview Table 122. Prestige Consumer Healthcare Dry Eye Syndrome Treatment Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 123. Prestige Consumer Healthcare Dry Eye Syndrome Treatment Product Portfolio Table 124. Prestige Consumer Healthcare Recent Development Table 125. OmniVision Pharma Company Information Table 126. OmniVision Pharma Business Overview Table 127. OmniVision Pharma Dry Eye Syndrome Treatment Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 128. OmniVision Pharma Dry Eye Syndrome Treatment Product Portfolio Table 129. OmniVision Pharma Recent Development Table 130. LION Company Information Table 131. LION Business Overview Table 132. LION Dry Eye Syndrome Treatment Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 133. LION Dry Eye Syndrome Treatment Product Portfolio Table 134. LION Recent Development Table 135. Kenvue (VISINE) Company Information Table 136. Kenvue (VISINE) Business Overview Table 137. Kenvue (VISINE) Dry Eye Syndrome Treatment Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 138. Kenvue (VISINE) Dry Eye Syndrome Treatment Product Portfolio Table 139. Kenvue (VISINE) Recent Development Table 140. Bausch & Lomb Company Information Table 141. Bausch & Lomb Business Overview Table 142. Bausch & Lomb Dry Eye Syndrome Treatment Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 143. Bausch & Lomb Dry Eye Syndrome Treatment Product Portfolio Table 144. Bausch & Lomb Recent Development Table 145. Akorn Company Information Table 146. Akorn Business Overview Table 147. Akorn Dry Eye Syndrome Treatment Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 148. Akorn Dry Eye Syndrome Treatment Product Portfolio Table 149. Akorn Recent Development Table 150. North America Dry Eye Syndrome Treatment Revenue by Type (2021-2026) & (US$ Million) Table 151. North America Dry Eye Syndrome Treatment Revenue by Type (2027-2032) & (US$ Million) Table 152. North America Dry Eye Syndrome Treatment Sales by Type (2021-2026) & (k units) Table 153. North America Dry Eye Syndrome Treatment Sales by Type (2027-2032) & (k units) Table 154. North America Dry Eye Syndrome Treatment Sales Price by Type (2021-2026) & (USD/unit) Table 155. North America Dry Eye Syndrome Treatment Sales Price by Type (2027-2032) & (USD/unit) Table 156. North America Dry Eye Syndrome Treatment Revenue by Application (2021-2026) & (US$ Million) Table 157. North America Dry Eye Syndrome Treatment Revenue by Application (2027-2032) & (US$ Million) Table 158. North America Dry Eye Syndrome Treatment Sales by Application (2021-2026) & (k units) Table 159. North America Dry Eye Syndrome Treatment Sales by Application (2027-2032) & (k units) Table 160. North America Dry Eye Syndrome Treatment Sales Price by Application (2021-2026) & (USD/unit) Table 161. North America Dry Eye Syndrome Treatment Sales Price by Application (2027-2032) & (USD/unit) Table 162. North America Dry Eye Syndrome Treatment Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 163. North America Dry Eye Syndrome Treatment Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 164. North America Dry Eye Syndrome Treatment Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 165. North America Dry Eye Syndrome Treatment Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 166. North America Dry Eye Syndrome Treatment Sales by Country (2021-2026) & (k units) Table 167. North America Dry Eye Syndrome Treatment Sales by Country (2027-2032) & (k units) Table 168. North America Dry Eye Syndrome Treatment Sales Price by Country (2021-2026) & (USD/unit) Table 169. North America Dry Eye Syndrome Treatment Sales Price by Country (2027-2032) & (USD/unit) Table 170. United States Dry Eye Syndrome Treatment Revenue (2021-2032) & (US$ Million) Table 171. Canada Dry Eye Syndrome Treatment Revenue (2021-2032) & (US$ Million) Table 172. Mexico Dry Eye Syndrome Treatment Revenue (2021-2032) & (US$ Million) Table 173. Europe Dry Eye Syndrome Treatment Revenue by Type (2021-2026) & (US$ Million) Table 174. Europe Dry Eye Syndrome Treatment Revenue by Type (2027-2032) & (US$ Million) Table 175. Europe Dry Eye Syndrome Treatment Sales by Type (2021-2026) & (k units) Table 176. Europe Dry Eye Syndrome Treatment Sales by Type (2027-2032) & (k units) Table 177. Europe Dry Eye Syndrome Treatment Sales Price by Type (2021-2026) & (USD/unit) Table 178. Europe Dry Eye Syndrome Treatment Sales Price by Type (2027-2032) & (USD/unit) Table 179. Europe Dry Eye Syndrome Treatment Revenue by Application (2021-2026) & (US$ Million) Table 180. Europe Dry Eye Syndrome Treatment Revenue by Application (2027-2032) & (US$ Million) Table 181. Europe Dry Eye Syndrome Treatment Sales by Application (2021-2026) & (k units) Table 182. Europe Dry Eye Syndrome Treatment Sales by Application (2027-2032) & (k units) Table 183. Europe Dry Eye Syndrome Treatment Sales Price by Application (2021-2026) & (USD/unit) Table 184. Europe Dry Eye Syndrome Treatment Sales Price by Application (2027-2032) & (USD/unit) Table 185. Europe Dry Eye Syndrome Treatment Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 186. Europe Dry Eye Syndrome Treatment Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 187. Europe Dry Eye Syndrome Treatment Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 188. Europe Dry Eye Syndrome Treatment Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 189. Europe Dry Eye Syndrome Treatment Sales by Country (2021-2026) & (k units) Table 190. Europe Dry Eye Syndrome Treatment Sales by Country (2027-2032) & (k units) Table 191. Europe Dry Eye Syndrome Treatment Sales Price by Country (2021-2026) & (USD/unit) Table 192. Europe Dry Eye Syndrome Treatment Sales Price by Country (2027-2032) & (USD/unit) Table 193. Germany Dry Eye Syndrome Treatment Revenue (2021-2032) & (US$ Million) Table 194. France Dry Eye Syndrome Treatment Revenue (2021-2032) & (US$ Million) Table 195. U.K. Dry Eye Syndrome Treatment Revenue (2021-2032) & (US$ Million) Table 196. Italy Dry Eye Syndrome Treatment Revenue (2021-2032) & (US$ Million) Table 197. Russia Dry Eye Syndrome Treatment Revenue (2021-2032) & (US$ Million) Table 198. Spain Dry Eye Syndrome Treatment Revenue (2021-2032) & (US$ Million) Table 199. Netherlands Dry Eye Syndrome Treatment Revenue (2021-2032) & (US$ Million) Table 200. Switzerland Dry Eye Syndrome Treatment Revenue (2021-2032) & (US$ Million) Table 201. Sweden Dry Eye Syndrome Treatment Revenue (2021-2032) & (US$ Million) Table 202. Poland Dry Eye Syndrome Treatment Revenue (2021-2032) & (US$ Million) Table 203. China Dry Eye Syndrome Treatment Revenue by Type (2021-2026) & (US$ Million) Table 204. China Dry Eye Syndrome Treatment Revenue by Type (2027-2032) & (US$ Million) Table 205. China Dry Eye Syndrome Treatment Sales by Type (2021-2026) & (k units) Table 206. China Dry Eye Syndrome Treatment Sales by Type (2027-2032) & (k units) Table 207. China Dry Eye Syndrome Treatment Sales Price by Type (2021-2026) & (USD/unit) Table 208. China Dry Eye Syndrome Treatment Sales Price by Type (2027-2032) & (USD/unit) Table 209. China Dry Eye Syndrome Treatment Revenue by Application (2021-2026) & (US$ Million) Table 210. China Dry Eye Syndrome Treatment Revenue by Application (2027-2032) & (US$ Million) Table 211. China Dry Eye Syndrome Treatment Sales by Application (2021-2026) & (k units) Table 212. China Dry Eye Syndrome Treatment Sales by Application (2027-2032) & (k units) Table 213. China Dry Eye Syndrome Treatment Sales Price by Application (2021-2026) & (USD/unit) Table 214. China Dry Eye Syndrome Treatment Sales Price by Application (2027-2032) & (USD/unit) Table 215. Asia Dry Eye Syndrome Treatment Revenue by Type (2021-2026) & (US$ Million) Table 216. Asia Dry Eye Syndrome Treatment Revenue by Type (2027-2032) & (US$ Million) Table 217. Asia Dry Eye Syndrome Treatment Sales by Type (2021-2026) & (k units) Table 218. Asia Dry Eye Syndrome Treatment Sales by Type (2027-2032) & (k units) Table 219. Asia Dry Eye Syndrome Treatment Sales Price by Type (2021-2026) & (USD/unit) Table 220. Asia Dry Eye Syndrome Treatment Sales Price by Type (2027-2032) & (USD/unit) Table 221. Asia Dry Eye Syndrome Treatment Revenue by Application (2021-2026) & (US$ Million) Table 222. Asia Dry Eye Syndrome Treatment Revenue by Application (2027-2032) & (US$ Million) Table 223. Asia Dry Eye Syndrome Treatment Sales by Application (2021-2026) & (k units) Table 224. Asia Dry Eye Syndrome Treatment Sales by Application (2027-2032) & (k units) Table 225. Asia Dry Eye Syndrome Treatment Sales Price by Application (2021-2026) & (USD/unit) Table 226. Asia Dry Eye Syndrome Treatment Sales Price by Application (2027-2032) & (USD/unit) Table 227. Asia Dry Eye Syndrome Treatment Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 228. Asia Dry Eye Syndrome Treatment Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 229. Asia Dry Eye Syndrome Treatment Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 230. Asia Dry Eye Syndrome Treatment Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 231. Asia Dry Eye Syndrome Treatment Sales by Country (2021-2026) & (k units) Table 232. Asia Dry Eye Syndrome Treatment Sales by Country (2027-2032) & (k units) Table 233. Asia Dry Eye Syndrome Treatment Sales Price by Country (2021-2026) & (USD/unit) Table 234. Asia Dry Eye Syndrome Treatment Sales Price by Country (2027-2032) & (USD/unit) Table 235. Japan Dry Eye Syndrome Treatment Revenue (2021-2032) & (US$ Million) Table 236. South Korea Dry Eye Syndrome Treatment Revenue (2021-2032) & (US$ Million) Table 237. India Dry Eye Syndrome Treatment Revenue (2021-2032) & (US$ Million) Table 238. Australia Dry Eye Syndrome Treatment Revenue (2021-2032) & (US$ Million) Table 239. Taiwan Dry Eye Syndrome Treatment Revenue (2021-2032) & (US$ Million) Table 240. Southeast Asia Dry Eye Syndrome Treatment Revenue (2021-2032) & (US$ Million) Table 241. SAMEA Dry Eye Syndrome Treatment Revenue by Type (2021-2026) & (US$ Million) Table 242. SAMEA Dry Eye Syndrome Treatment Revenue by Type (2027-2032) & (US$ Million) Table 243. SAMEA Dry Eye Syndrome Treatment Sales by Type (2021-2026) & (k units) Table 244. SAMEA Dry Eye Syndrome Treatment Sales by Type (2027-2032) & (k units) Table 245. SAMEA Dry Eye Syndrome Treatment Sales Price by Type (2021-2026) & (USD/unit) Table 246. SAMEA Dry Eye Syndrome Treatment Sales Price by Type (2027-2032) & (USD/unit) Table 247. SAMEA Dry Eye Syndrome Treatment Revenue by Application (2021-2026) & (US$ Million) Table 248. SAMEA Dry Eye Syndrome Treatment Revenue by Application (2027-2032) & (US$ Million) Table 249. SAMEA Dry Eye Syndrome Treatment Sales by Application (2021-2026) & (k units) Table 250. SAMEA Dry Eye Syndrome Treatment Sales by Application (2027-2032) & (k units) Table 251. SAMEA Dry Eye Syndrome Treatment Sales Price by Application (2021-2026) & (USD/unit) Table 252. SAMEA Dry Eye Syndrome Treatment Sales Price by Application (2027-2032) & (USD/unit) Table 253. SAMEA Dry Eye Syndrome Treatment Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 254. SAMEA Dry Eye Syndrome Treatment Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 255. SAMEA Dry Eye Syndrome Treatment Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 256. SAMEA Dry Eye Syndrome Treatment Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 257. SAMEA Dry Eye Syndrome Treatment Sales by Country (2021-2026) & (k units) Table 258. SAMEA Dry Eye Syndrome Treatment Sales by Country (2027-2032) & (k units) Table 259. SAMEA Dry Eye Syndrome Treatment Sales Price by Country (2021-2026) & (USD/unit) Table 260. SAMEA Dry Eye Syndrome Treatment Sales Price by Country (2027-2032) & (USD/unit) Table 261. Brazil Dry Eye Syndrome Treatment Revenue (2021-2032) & (US$ Million) Table 262. Argentina Dry Eye Syndrome Treatment Revenue (2021-2032) & (US$ Million) Table 263. Chile Dry Eye Syndrome Treatment Revenue (2021-2032) & (US$ Million) Table 264. Colombia Dry Eye Syndrome Treatment Revenue (2021-2032) & (US$ Million) Table 265. Peru Dry Eye Syndrome Treatment Revenue (2021-2032) & (US$ Million) Table 266. Saudi Arabia Dry Eye Syndrome Treatment Revenue (2021-2032) & (US$ Million) Table 267. Israel Dry Eye Syndrome Treatment Revenue (2021-2032) & (US$ Million) Table 268. UAE Dry Eye Syndrome Treatment Revenue (2021-2032) & (US$ Million) Table 269. Turkey Dry Eye Syndrome Treatment Revenue (2021-2032) & (US$ Million) Table 270. Iran Dry Eye Syndrome Treatment Revenue (2021-2032) & (US$ Million) Table 271. Egypt Dry Eye Syndrome Treatment Revenue (2021-2032) & (US$ Million) Table 272. Key Raw Materials Table 273. Raw Materials Key Suppliers Table 274. Dry Eye Syndrome Treatment Distributors List Table 275. Dry Eye Syndrome Treatment Customers List Table 276. Research Programs/Design for This Report Table 277. Authors List of This Report Table 278. Secondary Sources Table 279. Primary Sources List of Figures Figure 1. Dry Eye Syndrome Treatment Image Figure 2. Global Dry Eye Syndrome Treatment Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Dry Eye Syndrome Treatment Market Size Share 2021 VS 2025 VS 2032 Figure 4. Liquid Wipes Image Figure 5. Liquid Drops Image Figure 6. Eye Ointment Image Figure 7. Gel Image Figure 8. Other Image Figure 9. Global Dry Eye Syndrome Treatment Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Dry Eye Syndrome Treatment Market Size Share 2021 VS 2025 VS 2032 Figure 11. Clinic Image Figure 12. Hospital Image Figure 13. Home Care Image Figure 14. Global Dry Eye Syndrome Treatment Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Dry Eye Syndrome Treatment Revenue (2021-2032) & (US$ Million) Figure 16. Global Dry Eye Syndrome Treatment Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 17. Global Dry Eye Syndrome Treatment Revenue Market Share by Region: 2025 Versus 2032 Figure 18. Global Dry Eye Syndrome Treatment Revenue Market Share by Region (2021-2032) Figure 19. Global Dry Eye Syndrome Treatment Sales (2021-2032) & (k units) Figure 20. Global Dry Eye Syndrome Treatment Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 21. Global Dry Eye Syndrome Treatment Sales Market Share by Region (2021-2032) Figure 22. US & Canada & Mexico Dry Eye Syndrome Treatment Sales YoY (2021-2032) & (k units) Figure 23. Europe Dry Eye Syndrome Treatment Sales YoY (2021-2032) & (k units) Figure 24. China Dry Eye Syndrome Treatment Sales YoY (2021-2032) & (k units) Figure 25. Asia (Excluding China) Dry Eye Syndrome Treatment Sales YoY (2021-2032) & (k units) Figure 26. South America, Middle East and Africa Dry Eye Syndrome Treatment Sales YoY (2021-2032) & (k units) Figure 27. Global Dry Eye Syndrome Treatment Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 28. Global Dry Eye Syndrome Treatment Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 29. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 30. Global Dry Eye Syndrome Treatment Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 31. Global Dry Eye Syndrome Treatment Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Dry Eye Syndrome Treatment Revenue Market Share by Type (2021-2032) Figure 33. Global Dry Eye Syndrome Treatment Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 34. Global Dry Eye Syndrome Treatment Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 35. Global Dry Eye Syndrome Treatment Sales Market Share by Type (2021-2032) Figure 36. Global Dry Eye Syndrome Treatment Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 37. Global Dry Eye Syndrome Treatment Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Dry Eye Syndrome Treatment Revenue Market Share by Application (2021-2032) Figure 39. Global Dry Eye Syndrome Treatment Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 40. Global Dry Eye Syndrome Treatment Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 41. Global Dry Eye Syndrome Treatment Sales Market Share by Application (2021-2032) Figure 42. North America Dry Eye Syndrome Treatment Revenue Share by Type (2021-2032) Figure 43. North America Dry Eye Syndrome Treatment Sales Share by Type (2021-2032) Figure 44. North America Dry Eye Syndrome Treatment Revenue Share by Application (2021-2032) Figure 45. North America Dry Eye Syndrome Treatment Sales Share by Application (2021-2032) Figure 46. North America Dry Eye Syndrome Treatment Revenue Share by Country (2021-2032) Figure 47. North America Dry Eye Syndrome Treatment Sales Share by Country (2021-2032) Figure 48. Europe Dry Eye Syndrome Treatment Revenue Share by Type (2021-2032) Figure 49. Europe Dry Eye Syndrome Treatment Sales Share by Type (2021-2032) Figure 50. Europe Dry Eye Syndrome Treatment Revenue Share by Application (2021-2032) Figure 51. Europe Dry Eye Syndrome Treatment Sales Share by Application (2021-2032) Figure 52. Europe Dry Eye Syndrome Treatment Revenue Share by Country (2021-2032) Figure 53. Europe Dry Eye Syndrome Treatment Sales Share by Country (2021-2032) Figure 54. China Dry Eye Syndrome Treatment Revenue Share by Type (2021-2032) Figure 55. China Dry Eye Syndrome Treatment Sales Share by Type (2021-2032) Figure 56. China Dry Eye Syndrome Treatment Revenue Share by Application (2021-2032) Figure 57. China Dry Eye Syndrome Treatment Sales Share by Application (2021-2032) Figure 58. Asia Dry Eye Syndrome Treatment Revenue Share by Type (2021-2032) Figure 59. Asia Dry Eye Syndrome Treatment Sales Share by Type (2021-2032) Figure 60. Asia Dry Eye Syndrome Treatment Revenue Share by Application (2021-2032) Figure 61. Asia Dry Eye Syndrome Treatment Sales Share by Application (2021-2032) Figure 62. Asia Dry Eye Syndrome Treatment Revenue Share by Country (2021-2032) Figure 63. Asia Dry Eye Syndrome Treatment Sales Share by Country (2021-2032) Figure 64. SAMEA Dry Eye Syndrome Treatment Revenue Share by Type (2021-2032) Figure 65. SAMEA Dry Eye Syndrome Treatment Sales Share by Type (2021-2032) Figure 66. SAMEA Dry Eye Syndrome Treatment Revenue Share by Application (2021-2032) Figure 67. SAMEA Dry Eye Syndrome Treatment Sales Share by Application (2021-2032) Figure 68. SAMEA Dry Eye Syndrome Treatment Revenue Share by Country (2021-2032) Figure 69. SAMEA Dry Eye Syndrome Treatment Sales Share by Country (2021-2032) Figure 70. Dry Eye Syndrome Treatment Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Dry Eye Syndrome Treatment Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Liquid Wipes
  • Liquid Drops
  • Eye Ointment
  • Gel
  • Other
Applications
  • Clinic
  • Hospital
  • Home Care
Companies covered
  • Sun Pharmaceutical
  • Johnson & Johnson
  • Novartis
  • United Laboratories
  • Jianfeng Group
  • Alcon
  • AbbVie
  • URSAPHARM
  • Thea pharmaceuticals
  • SIMILASAN
  • Santen Pharma
  • Rohto
  • Prestige Consumer Healthcare
  • OmniVision Pharma
  • LION
  • Kenvue (VISINE)
  • Bausch & Lomb
  • Akorn

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Dry Eye Syndrome Treatment Market by Type
  3. 1.2.1 Global Dry Eye Syndrome Treatment Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Liquid Wipes
  5. 1.2.3 Liquid Drops
  6. 1.2.4 Eye Ointment
  7. 1.2.5 Gel
  8. 1.2.6 Other
  9. 1.3 Dry Eye Syndrome Treatment Market by Application
  10. 1.3.1 Global Dry Eye Syndrome Treatment Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Clinic
  12. 1.3.3 Hospital
  13. 1.3.4 Home Care
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Dry Eye Syndrome Treatment Market Dynamics
  1. 2.1 Dry Eye Syndrome Treatment Industry Trends
  2. 2.2 Dry Eye Syndrome Treatment Industry Drivers
  3. 2.3 Dry Eye Syndrome Treatment Industry Opportunities and Challenges
  4. 2.4 Dry Eye Syndrome Treatment Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Dry Eye Syndrome Treatment Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Dry Eye Syndrome Treatment Revenue by Region
  3. 3.2.1 Global Dry Eye Syndrome Treatment Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Dry Eye Syndrome Treatment Revenue by Region (2021-2026)
  5. 3.2.3 Global Dry Eye Syndrome Treatment Revenue by Region (2027-2032)
  6. 3.2.4 Global Dry Eye Syndrome Treatment Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Dry Eye Syndrome Treatment Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Dry Eye Syndrome Treatment Sales by Region
  9. 3.4.1 Global Dry Eye Syndrome Treatment Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Dry Eye Syndrome Treatment Sales by Region (2021-2026)
  11. 3.4.3 Global Dry Eye Syndrome Treatment Sales by Region (2027-2032)
  12. 3.4.4 Global Dry Eye Syndrome Treatment Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Dry Eye Syndrome Treatment Revenue by Manufacturers
  2. 4.1.1 Global Dry Eye Syndrome Treatment Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Dry Eye Syndrome Treatment Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Dry Eye Syndrome Treatment Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Dry Eye Syndrome Treatment Sales by Manufacturers
  6. 4.2.1 Global Dry Eye Syndrome Treatment Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Dry Eye Syndrome Treatment Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Dry Eye Syndrome Treatment Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Dry Eye Syndrome Treatment Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Dry Eye Syndrome Treatment Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Dry Eye Syndrome Treatment Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Dry Eye Syndrome Treatment Manufacturers, Product Type & Application
  13. 4.7 Global Dry Eye Syndrome Treatment Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Dry Eye Syndrome Treatment Market CR5 and HHI
  16. 4.8.2 2025 Dry Eye Syndrome Treatment Tier 1, Tier 2, and Tier 3
5 Dry Eye Syndrome Treatment Market by Type
  1. 5.1 Global Dry Eye Syndrome Treatment Revenue by Type
  2. 5.1.1 Global Dry Eye Syndrome Treatment Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Dry Eye Syndrome Treatment Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Dry Eye Syndrome Treatment Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Dry Eye Syndrome Treatment Sales by Type
  6. 5.2.1 Global Dry Eye Syndrome Treatment Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Dry Eye Syndrome Treatment Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Dry Eye Syndrome Treatment Sales Market Share by Type (2021-2032)
  9. 5.3 Global Dry Eye Syndrome Treatment Price by Type
6 Dry Eye Syndrome Treatment Market by Application
  1. 6.1 Global Dry Eye Syndrome Treatment Revenue by Application
  2. 6.1.1 Global Dry Eye Syndrome Treatment Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Dry Eye Syndrome Treatment Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Dry Eye Syndrome Treatment Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Dry Eye Syndrome Treatment Sales by Application
  6. 6.2.1 Global Dry Eye Syndrome Treatment Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Dry Eye Syndrome Treatment Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Dry Eye Syndrome Treatment Sales Market Share by Application (2021-2032)
  9. 6.3 Global Dry Eye Syndrome Treatment Price by Application
7 Company Profiles
  1. 7.1 Sun Pharmaceutical
  2. 7.1.1 Sun Pharmaceutical Company Information
  3. 7.1.2 Sun Pharmaceutical Business Overview
  4. 7.1.3 Sun Pharmaceutical Dry Eye Syndrome Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Sun Pharmaceutical Dry Eye Syndrome Treatment Product Portfolio
  6. 7.1.5 Sun Pharmaceutical Recent Developments
  7. 7.2 Johnson & Johnson
  8. 7.2.1 Johnson & Johnson Company Information
  9. 7.2.2 Johnson & Johnson Business Overview
  10. 7.2.3 Johnson & Johnson Dry Eye Syndrome Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Johnson & Johnson Dry Eye Syndrome Treatment Product Portfolio
  12. 7.2.5 Johnson & Johnson Recent Developments
  13. 7.3 Novartis
  14. 7.3.1 Novartis Company Information
  15. 7.3.2 Novartis Business Overview
  16. 7.3.3 Novartis Dry Eye Syndrome Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Novartis Dry Eye Syndrome Treatment Product Portfolio
  18. 7.3.5 Novartis Recent Developments
  19. 7.4 United Laboratories
  20. 7.4.1 United Laboratories Company Information
  21. 7.4.2 United Laboratories Business Overview
  22. 7.4.3 United Laboratories Dry Eye Syndrome Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 United Laboratories Dry Eye Syndrome Treatment Product Portfolio
  24. 7.4.5 United Laboratories Recent Developments
  25. 7.5 Jianfeng Group
  26. 7.5.1 Jianfeng Group Company Information
  27. 7.5.2 Jianfeng Group Business Overview
  28. 7.5.3 Jianfeng Group Dry Eye Syndrome Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Jianfeng Group Dry Eye Syndrome Treatment Product Portfolio
  30. 7.5.5 Jianfeng Group Recent Developments
  31. 7.6 Alcon
  32. 7.6.1 Alcon Company Information
  33. 7.6.2 Alcon Business Overview
  34. 7.6.3 Alcon Dry Eye Syndrome Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Alcon Dry Eye Syndrome Treatment Product Portfolio
  36. 7.6.5 Alcon Recent Developments
  37. 7.7 AbbVie
  38. 7.7.1 AbbVie Company Information
  39. 7.7.2 AbbVie Business Overview
  40. 7.7.3 AbbVie Dry Eye Syndrome Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 AbbVie Dry Eye Syndrome Treatment Product Portfolio
  42. 7.7.5 AbbVie Recent Developments
  43. 7.8 URSAPHARM
  44. 7.8.1 URSAPHARM Company Information
  45. 7.8.2 URSAPHARM Business Overview
  46. 7.8.3 URSAPHARM Dry Eye Syndrome Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 URSAPHARM Dry Eye Syndrome Treatment Product Portfolio
  48. 7.8.5 URSAPHARM Recent Developments
  49. 7.9 Thea pharmaceuticals
  50. 7.9.1 Thea pharmaceuticals Company Information
  51. 7.9.2 Thea pharmaceuticals Business Overview
  52. 7.9.3 Thea pharmaceuticals Dry Eye Syndrome Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Thea pharmaceuticals Dry Eye Syndrome Treatment Product Portfolio
  54. 7.9.5 Thea pharmaceuticals Recent Developments
  55. 7.10 SIMILASAN
  56. 7.10.1 SIMILASAN Company Information
  57. 7.10.2 SIMILASAN Business Overview
  58. 7.10.3 SIMILASAN Dry Eye Syndrome Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 SIMILASAN Dry Eye Syndrome Treatment Product Portfolio
  60. 7.10.5 SIMILASAN Recent Developments
  61. 7.11 Santen Pharma
  62. 7.11.1 Santen Pharma Company Information
  63. 7.11.2 Santen Pharma Business Overview
  64. 7.11.3 Santen Pharma Dry Eye Syndrome Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Santen Pharma Dry Eye Syndrome Treatment Product Portfolio
  66. 7.11.5 Santen Pharma Recent Developments
  67. 7.12 Rohto
  68. 7.12.1 Rohto Company Information
  69. 7.12.2 Rohto Business Overview
  70. 7.12.3 Rohto Dry Eye Syndrome Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Rohto Dry Eye Syndrome Treatment Product Portfolio
  72. 7.12.5 Rohto Recent Developments
  73. 7.13 Prestige Consumer Healthcare
  74. 7.13.1 Prestige Consumer Healthcare Company Information
  75. 7.13.2 Prestige Consumer Healthcare Business Overview
  76. 7.13.3 Prestige Consumer Healthcare Dry Eye Syndrome Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Prestige Consumer Healthcare Dry Eye Syndrome Treatment Product Portfolio
  78. 7.13.5 Prestige Consumer Healthcare Recent Developments
  79. 7.14 OmniVision Pharma
  80. 7.14.1 OmniVision Pharma Company Information
  81. 7.14.2 OmniVision Pharma Business Overview
  82. 7.14.3 OmniVision Pharma Dry Eye Syndrome Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 OmniVision Pharma Dry Eye Syndrome Treatment Product Portfolio
  84. 7.14.5 OmniVision Pharma Recent Developments
  85. 7.15 LION
  86. 7.15.1 LION Company Information
  87. 7.15.2 LION Business Overview
  88. 7.15.3 LION Dry Eye Syndrome Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 LION Dry Eye Syndrome Treatment Product Portfolio
  90. 7.15.5 LION Recent Developments
  91. 7.16 Kenvue (VISINE)
  92. 7.16.1 Kenvue (VISINE) Company Information
  93. 7.16.2 Kenvue (VISINE) Business Overview
  94. 7.16.3 Kenvue (VISINE) Dry Eye Syndrome Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Kenvue (VISINE) Dry Eye Syndrome Treatment Product Portfolio
  96. 7.16.5 Kenvue (VISINE) Recent Developments
  97. 7.17 Bausch & Lomb
  98. 7.17.1 Bausch & Lomb Company Information
  99. 7.17.2 Bausch & Lomb Business Overview
  100. 7.17.3 Bausch & Lomb Dry Eye Syndrome Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Bausch & Lomb Dry Eye Syndrome Treatment Product Portfolio
  102. 7.17.5 Bausch & Lomb Recent Developments
  103. 7.18 Akorn
  104. 7.18.1 Akorn Company Information
  105. 7.18.2 Akorn Business Overview
  106. 7.18.3 Akorn Dry Eye Syndrome Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 Akorn Dry Eye Syndrome Treatment Product Portfolio
  108. 7.18.5 Akorn Recent Developments
8 North America
  1. 8.1 North America Dry Eye Syndrome Treatment Market Size by Type
  2. 8.1.1 North America Dry Eye Syndrome Treatment Revenue by Type (2021-2032)
  3. 8.1.2 North America Dry Eye Syndrome Treatment Sales by Type (2021-2032)
  4. 8.1.3 North America Dry Eye Syndrome Treatment Price by Type (2021-2032)
  5. 8.2 North America Dry Eye Syndrome Treatment Market Size by Application
  6. 8.2.1 North America Dry Eye Syndrome Treatment Revenue by Application (2021-2032)
  7. 8.2.2 North America Dry Eye Syndrome Treatment Sales by Application (2021-2032)
  8. 8.2.3 North America Dry Eye Syndrome Treatment Price by Application (2021-2032)
  9. 8.3 North America Dry Eye Syndrome Treatment Market Size by Country
  10. 8.3.1 North America Dry Eye Syndrome Treatment Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Dry Eye Syndrome Treatment Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Dry Eye Syndrome Treatment Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Dry Eye Syndrome Treatment Market Size by Type
  2. 9.1.1 Europe Dry Eye Syndrome Treatment Revenue by Type (2021-2032)
  3. 9.1.2 Europe Dry Eye Syndrome Treatment Sales by Type (2021-2032)
  4. 9.1.3 Europe Dry Eye Syndrome Treatment Price by Type (2021-2032)
  5. 9.2 Europe Dry Eye Syndrome Treatment Market Size by Application
  6. 9.2.1 Europe Dry Eye Syndrome Treatment Revenue by Application (2021-2032)
  7. 9.2.2 Europe Dry Eye Syndrome Treatment Sales by Application (2021-2032)
  8. 9.2.3 Europe Dry Eye Syndrome Treatment Price by Application (2021-2032)
  9. 9.3 Europe Dry Eye Syndrome Treatment Market Size by Country
  10. 9.3.1 Europe Dry Eye Syndrome Treatment Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Dry Eye Syndrome Treatment Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Dry Eye Syndrome Treatment Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Dry Eye Syndrome Treatment Market Size by Type
  2. 10.1.1 China Dry Eye Syndrome Treatment Revenue by Type (2021-2032)
  3. 10.1.2 China Dry Eye Syndrome Treatment Sales by Type (2021-2032)
  4. 10.1.3 China Dry Eye Syndrome Treatment Price by Type (2021-2032)
  5. 10.2 China Dry Eye Syndrome Treatment Market Size by Application
  6. 10.2.1 China Dry Eye Syndrome Treatment Revenue by Application (2021-2032)
  7. 10.2.2 China Dry Eye Syndrome Treatment Sales by Application (2021-2032)
  8. 10.2.3 China Dry Eye Syndrome Treatment Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Dry Eye Syndrome Treatment Market Size by Type
  2. 11.1.1 Asia Dry Eye Syndrome Treatment Revenue by Type (2021-2032)
  3. 11.1.2 Asia Dry Eye Syndrome Treatment Sales by Type (2021-2032)
  4. 11.1.3 Asia Dry Eye Syndrome Treatment Price by Type (2021-2032)
  5. 11.2 Asia Dry Eye Syndrome Treatment Market Size by Application
  6. 11.2.1 Asia Dry Eye Syndrome Treatment Revenue by Application (2021-2032)
  7. 11.2.2 Asia Dry Eye Syndrome Treatment Sales by Application (2021-2032)
  8. 11.2.3 Asia Dry Eye Syndrome Treatment Price by Application (2021-2032)
  9. 11.3 Asia Dry Eye Syndrome Treatment Market Size by Country
  10. 11.3.1 Asia Dry Eye Syndrome Treatment Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Dry Eye Syndrome Treatment Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Dry Eye Syndrome Treatment Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Dry Eye Syndrome Treatment Market Size by Type
  2. 12.1.1 SAMEA Dry Eye Syndrome Treatment Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Dry Eye Syndrome Treatment Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Dry Eye Syndrome Treatment Price by Type (2021-2032)
  5. 12.2 SAMEA Dry Eye Syndrome Treatment Market Size by Application
  6. 12.2.1 SAMEA Dry Eye Syndrome Treatment Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Dry Eye Syndrome Treatment Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Dry Eye Syndrome Treatment Price by Application (2021-2032)
  9. 12.3 SAMEA Dry Eye Syndrome Treatment Market Size by Country
  10. 12.3.1 SAMEA Dry Eye Syndrome Treatment Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Dry Eye Syndrome Treatment Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Dry Eye Syndrome Treatment Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Dry Eye Syndrome Treatment Value Chain Analysis
  2. 13.1.1 Dry Eye Syndrome Treatment Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Dry Eye Syndrome Treatment Production Mode & Process
  6. 13.2 Dry Eye Syndrome Treatment Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Dry Eye Syndrome Treatment Distributors
  9. 13.2.3 Dry Eye Syndrome Treatment Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst